• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 年至 2016 年中国及亚人群缺血性心脏病负担的时间和空间趋势:2016 年全球疾病负担研究中的社会经济数据。

Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study.

机构信息

"Health Shandong" Major Social Risk Prediction and Governance Collaborative Innovation Center, School of Public Health and Management, Weifang Medical University, No.7166 Baotong Xi Street, Weicheng District, Weifang, 261053, China.

Chinese Center for Disease Control and Prevention, No.27 Nanwei Road, Xicheng District, Beijing, 100050, China.

出版信息

BMC Cardiovasc Disord. 2020 May 24;20(1):243. doi: 10.1186/s12872-020-01530-0.

DOI:10.1186/s12872-020-01530-0
PMID:32448161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7247238/
Abstract

BACKGROUND

Ischemic heart disease (IHD) is the leading cause of premature death which poses public health challenges worldwide. Previous studies focused on the overall population in China. However, variations in temporal and spatial patterns across subgroups remain unknown. This study was to analyze how the IHD burden among Chinese and subgroup populations changes in response to temporal and spatial trends from 1990 to 2016.

METHODS

Based on data from the updated estimate in the 2016 Global Burden of Disease (GBD) study, we used years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs) to describe the IHD burden. The percentage and annual average percentage changes were applied to illustrate temporal and spatial variations of the IHD burden stratified by age, sex, and province, over the periods 1990-2016, 1990-2005, and 2005-2016. We estimate population-attributable fraction (PAF) for 24 modifiable risk factors at the provincial level in 2016.

RESULTS

YLD rates, YLL rates, and DALY rates for IHD underwent a notable increase among all age groups and increased by 119.4, 83.3, and 84.5% nationally from 1990 to 2016. In YLD rates, a greater increase was seen in females (124.4%) compared to males (114.0%), while males experienced a more substantial increase than that in females in YLL rates (99.3% vs. 60.5%) and DALY rates (99.7% vs. 63.2%) from 1990 to 2016. Compared with 1990-2005, annual average changes in the overall population in YLL rates (3.5% vs. 1.8%) and DALY rates (3.5% vs. 1.9%) showed a tardier increase whereas an opposite increasing trend of YLD rates (3.5% vs. 4.0%) was observed between 2005 and 2016. Geographically, all provinces saw declines in the YLLs/YLDs ratio from 2005 to 2016, with seventeen of thirty-three provinces showing an upward trend between 1990 and 2005. Most provinces witnessed a remarkable upsurge in the age-standardised DALY rate from 1990 to 2016 whereas the economically advantaged region Macao (52.2%) saw the most marked reduction. High systolic blood pressure and high LDL cholesterol remained the two leading risk factors of IHD in all provinces in 2016. Diet high in sodium was the leading behavioral risks in twenty-eight provinces with smoking heading the list in five provinces.

CONCLUSIONS

China has made significant achievements in preventing premature death from IHD along with the increased risk of disability. Substantial disparities in temporal and spatial trends of the IHD burden emphasize concerns for elderly men and those in economically disadvantaged regions with resource constraints. Regional differences in the IHD burden can be partly explained by modifiable risk factors. By having identified these disparities, targeted IHD prevention and control strategies will help to bridge these gaps.

摘要

背景

缺血性心脏病(IHD)是导致全球人口过早死亡的主要原因,对公共卫生构成挑战。之前的研究集中在中国的整体人口。然而,不同亚组人群的时空模式变化仍不清楚。本研究旨在分析 1990 年至 2016 年期间,中国和亚组人群的 IHD 负担如何随时间和空间趋势变化。

方法

基于更新的 2016 年全球疾病负担(GBD)研究数据,我们使用失能生命年(YLDs)、生命损失年(YLLs)和伤残调整生命年(DALYs)来描述 IHD 负担。1990-2016 年、1990-2005 年和 2005-2016 年期间,我们使用年龄、性别和省份分层的百分比和年平均百分比变化来描述 IHD 负担的时空变化。我们估计了 2016 年省级 24 个可改变风险因素的人群归因分数(PAF)。

结果

1990 年至 2016 年,所有年龄组的 IHD 的 YLD 率、YLL 率和 DALY 率均显著上升,全国分别上升了 119.4%、83.3%和 84.5%。在 YLD 率方面,女性(124.4%)的增幅大于男性(114.0%),而男性在 YLL 率(99.3%对 60.5%)和 DALY 率(99.7%对 63.2%)方面的增幅大于女性。与 1990-2005 年相比,2005-2016 年,总人口的 YLL 率(3.5%对 1.8%)和 DALY 率(3.5%对 1.9%)的年平均变化呈较慢增长趋势,而 YLD 率的上升趋势相反(3.5%对 4.0%)。在地理上,所有省份的 YLLs/YLDs 比值从 2005 年到 2016 年都有所下降,33 个省份中有 17 个在 1990 年至 2005 年期间呈上升趋势。1990 年至 2016 年,大多数省份的年龄标准化 DALY 率显著上升,而经济发达地区澳门(52.2%)的下降幅度最大。高收缩压和高 LDL 胆固醇仍然是 2016 年所有省份的两个主要 IHD 风险因素。在 28 个省份中,高钠饮食是主要的行为风险因素,而在 5 个省份中,吸烟是主要的风险因素。

结论

中国在预防 IHD 导致的过早死亡方面取得了显著成就,同时残疾风险也有所增加。IHD 负担的时空趋势存在显著差异,这强调了老年人和经济贫困地区男性的问题,这些地区资源有限。IHD 负担的区域差异部分可以用可改变的风险因素来解释。通过识别这些差异,可以制定有针对性的 IHD 预防和控制策略,帮助缩小这些差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/a0699a34004f/12872_2020_1530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/6590aa7065d4/12872_2020_1530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/00b0eb967aea/12872_2020_1530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/a0699a34004f/12872_2020_1530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/6590aa7065d4/12872_2020_1530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/00b0eb967aea/12872_2020_1530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d5/7247238/a0699a34004f/12872_2020_1530_Fig3_HTML.jpg

相似文献

1
Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study.1990 年至 2016 年中国及亚人群缺血性心脏病负担的时间和空间趋势:2016 年全球疾病负担研究中的社会经济数据。
BMC Cardiovasc Disord. 2020 May 24;20(1):243. doi: 10.1186/s12872-020-01530-0.
2
[Trends of burden on ischemic heart disease and epidemiological transition of related risk factors in China, 1990-2017].[1990 - 2017年中国缺血性心脏病负担趋势及相关危险因素的流行病学转变]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1703-1709. doi: 10.3760/cma.j.cn112338-20191018-00743.
3
Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study.1990年至2015年中国缺血性心脏病负担及可归因风险因素:全球疾病负担2015研究结果
BMC Cardiovasc Disord. 2018 Feb 2;18(1):18. doi: 10.1186/s12872-018-0761-0.
4
The burden of ischemic heart disease and type 2 diabetes mellitus attributable to diet high in sugar-sweetened beverages in China: An analysis for the Global Burden of Disease Study 2017.中国因含糖饮料摄入过高导致的缺血性心脏病和 2 型糖尿病负担:2017 年全球疾病负担研究分析。
J Diabetes. 2021 Jun;13(6):482-493. doi: 10.1111/1753-0407.13132. Epub 2020 Nov 24.
5
Disease burden and risk factors of ischemic heart disease in China during 1990-2019 based on the Global Burden of Disease 2019 report: A systematic analysis.基于 2019 年全球疾病负担研究报告:系统分析 1990-2019 年中国缺血性心脏病的疾病负担和风险因素。
Front Public Health. 2022 Nov 3;10:973317. doi: 10.3389/fpubh.2022.973317. eCollection 2022.
6
Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.波兰与其他中东欧国家 1990-2017 年疾病负担变化的比较:2017 年全球疾病负担研究的系统分析。
PLoS One. 2020 Mar 2;15(3):e0226766. doi: 10.1371/journal.pone.0226766. eCollection 2020.
7
Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.1990 年至 2019 年 137 个中低收入国家慢性肾脏病负担及其归因风险负担:来自 2019 年全球疾病负担研究的结果。
BMC Nephrol. 2022 Jan 5;23(1):17. doi: 10.1186/s12882-021-02597-3.
8
Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019.全球及各国 1990 年至 2019 年动脉粥样硬化负担变化趋势分析:基于 2019 年全球疾病负担研究结果
Chin Med J (Engl). 2023 Oct 20;136(20):2442-2450. doi: 10.1097/CM9.0000000000002839. Epub 2023 Sep 5.
9
Burden and trend of ischemic heart disease and colorectal cancer attributable to a diet low in fiber in China, 1990-2017: findings from the Global Burden of Disease Study 2017.中国 1990-2017 年因膳食纤维摄入不足导致的缺血性心脏病和结直肠癌负担及趋势:来自 2017 年全球疾病负担研究的发现。
Eur J Nutr. 2021 Oct;60(7):3819-3827. doi: 10.1007/s00394-021-02556-6. Epub 2021 Apr 14.
10
Ischemic heart disease deaths, disability-adjusted life years and risk factors in Fujian, China during 1990-2013: Data from the Global Burden of Disease Study 2013.1990 - 2013年中国福建省缺血性心脏病死亡、伤残调整生命年及风险因素:来自《2013年全球疾病负担研究》的数据
Int J Cardiol. 2016 Jul 1;214:265-9. doi: 10.1016/j.ijcard.2016.03.236. Epub 2016 Apr 4.

引用本文的文献

1
Spatial-temporal variations of stroke mortality worldwide from 2000 to 2021.2000年至2021年全球卒中死亡率的时空变化
BMC Public Health. 2025 Feb 20;25(1):711. doi: 10.1186/s12889-025-21774-9.
2
Construction and validation of a personalized risk prediction model for in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.急性心肌梗死接受经皮冠状动脉介入治疗患者院内死亡个性化风险预测模型的构建与验证
Clinics (Sao Paulo). 2025 Feb 1;80:100580. doi: 10.1016/j.clinsp.2025.100580. eCollection 2025.
3
Global Burden of Early-Onset Ischemic Heart Disease, 1990 to 2019.

本文引用的文献

1
Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study.1990 年至 2013 年 187 个国家特定疾病和损伤对健康调整期望寿命变化的贡献:回顾性观察研究。
BMJ. 2019 Mar 27;364:l969. doi: 10.1136/bmj.l969.
2
Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study.中国心血管疾病负担,1990-2016 年:来自 2016 年全球疾病负担研究的发现。
JAMA Cardiol. 2019 Apr 1;4(4):342-352. doi: 10.1001/jamacardio.2019.0295.
3
Epidemiology of cardiovascular disease in China: current features and implications.
1990年至2019年早发性缺血性心脏病的全球负担
JACC Adv. 2024 Dec 20;4(1):101466. doi: 10.1016/j.jacadv.2024.101466. eCollection 2025 Jan.
4
Cardiovascular health in perspective: a comprehensive five-year geodatabase of hospitalizations and environmental factors in Mashhad, Iran.心血管健康展望:伊朗马什哈德住院情况及环境因素的五年综合地理数据库
BMC Res Notes. 2025 Jan 13;18(1):12. doi: 10.1186/s13104-025-07087-5.
5
Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults.在中国和欧洲成年人中使用血浆蛋白质组学、传统危险因素和多基因评分预测缺血性心脏病风险
Eur J Epidemiol. 2024 Nov;39(11):1229-1240. doi: 10.1007/s10654-024-01168-8. Epub 2024 Nov 22.
6
Global, regional, and national time trends in ischaemic heart disease incidence over three decades (1990-2019): an age-period-cohort analysis of the global burden of disease study 2019.全球、区域和国家三十年(1990 - 2019年)缺血性心脏病发病率的时间趋势:全球疾病负担研究2019的年龄-时期-队列分析
Front Cardiovasc Med. 2024 Nov 1;11:1396380. doi: 10.3389/fcvm.2024.1396380. eCollection 2024.
7
The incidence, mortality and disease burden of cardiovascular diseases in China: a comparative study with the United States and Japan based on the GBD 2019 time trend analysis.中国心血管疾病的发病率、死亡率及疾病负担:基于全球疾病负担研究(GBD)2019时间趋势分析与美国和日本的比较研究
Front Cardiovasc Med. 2024 Sep 18;11:1408487. doi: 10.3389/fcvm.2024.1408487. eCollection 2024.
8
Scutellarin Protects against Myocardial Ischemia-reperfusion Injury by Enhancing Aerobic Glycolysis through miR-34c-5p/ALDOA Axis.灯盏花素通过miR-34c-5p/醛缩酶A轴增强有氧糖酵解来预防心肌缺血再灌注损伤。
Int J Appl Basic Med Res. 2024 Apr-Jun;14(2):85-93. doi: 10.4103/ijabmr.ijabmr_415_23. Epub 2024 May 24.
9
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.血浆蛋白质组学鉴定缺血性心脏病的药物靶点。
J Am Coll Cardiol. 2023 Nov 14;82(20):1906-1920. doi: 10.1016/j.jacc.2023.09.804.
10
Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis.2010 年至 2019 年中国缺血性心脏病死亡率趋势分析:联合分析。
BMC Public Health. 2023 Apr 4;23(1):644. doi: 10.1186/s12889-023-15549-3.
中国心血管疾病的流行病学:现状特征及影响。
Nat Rev Cardiol. 2019 Apr;16(4):203-212. doi: 10.1038/s41569-018-0119-4.
4
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.中国高血压现状:2012-2015 年中国高血压调查结果。
Circulation. 2018 May 29;137(22):2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380. Epub 2018 Feb 15.
5
Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study.1990年至2015年中国缺血性心脏病负担及可归因风险因素:全球疾病负担2015研究结果
BMC Cardiovasc Disord. 2018 Feb 2;18(1):18. doi: 10.1186/s12872-018-0761-0.
6
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).中国高血压的患病率、知晓率、治疗率和控制率:一项基于人群筛查研究的 170 万成年人数据(中国高血压调查)。
Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5.
7
[Trend analysis of the burden of ischemic heart disease in China, 1990 to 2015].[1990年至2015年中国缺血性心脏病负担的趋势分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Oct 6;51(10):915-921. doi: 10.3760/cma.j.issn.0253-9624.2017.10.009.
8
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 84 种行为、环境和职业以及代谢风险或风险组合的比较风险评估,1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8.
9
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
10
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.